Compare SuRo Capital Corp. with Similar Stocks
Stock DNA
Capital Markets
USD 233 Million (Micro Cap)
NA (Loss Making)
NA
5.06%
-999,999.00
29.76%
1.01
Revenue and Profits:
Net Sales:
6 Million
(Quarterly Results - Sep 2025)
Net Profit:
7 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
77.47%
0%
77.47%
6 Months
46.25%
0%
46.25%
1 Year
119.83%
0%
119.83%
2 Years
166.47%
0%
166.47%
3 Years
24.55%
0%
24.55%
4 Years
-33.13%
0%
-33.13%
5 Years
33.63%
0%
33.63%
SuRo Capital Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
1.45%
EBIT Growth (5y)
50.18%
EBIT to Interest (avg)
36.22
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0.27%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
30.20%
ROCE (avg)
29.14%
ROE (avg)
17.10%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.11
EV to EBIT
-13.28
EV to EBITDA
-13.28
EV to Capital Employed
1.12
EV to Sales
-135.01
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-8.45%
ROE (Latest)
-10.76%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 6 Schemes (8.27%)
Foreign Institutions
Held by 7 Foreign Institutions (0.71%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
5.70
21.40
-73.36%
Operating Profit (PBDIT) excl Other Income
8.70
63.40
-86.28%
Interest
1.30
1.30
Exceptional Items
0.00
0.00
Consolidate Net Profit
7.40
62.30
-88.12%
Operating Profit Margin (Excl OI)
1,537.10%
2,964.70%
-142.76%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is -73.36% vs 4,180.00% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is -88.12% vs 7,887.50% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
-0.50
-5.40
90.74%
Operating Profit (PBDIT) excl Other Income
-33.20
10.50
-416.19%
Interest
4.80
4.90
-2.04%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-38.10
5.10
-847.06%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 90.74% vs -125.00% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -847.06% vs 103.86% in Dec 2023
About SuRo Capital Corp. 
SuRo Capital Corp.
Capital Markets
SuRo Capital Corp. (SuRo Capital), formerly Sutter Rock Capital Corp., is an investment fund that seeks to invest in venture-backed private companies. SuRo Capital seeks to create a portfolio of private companies via a repeatable investment approach, as well as to provide investors with access to such companies through its publicly traded common stock.
Company Coordinates 
Company Details
ONE SANSOME STREET, SUITE 730 , SAN FRANCISCO CA : 94104
Registrar Details






